<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum total <z:chebi fb="4" ids="30660">thyroxine</z:chebi>, triiodothyronine, and thyrotropin response to thyrotropin-releasing hormone (TRH-TSH test) were measured in 126 consecutive patients admitted with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>: 33 patients with an <z:hpo ids='HP_0011009'>acute</z:hpo> arterial limb embolism (Group I), 31 patients with an <z:hpo ids='HP_0011009'>acute</z:hpo> embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> (Group II), and 62 patients without any <z:mp ids='MP_0006134'>arterial occlusion</z:mp> (Group III) </plain></SENT>
<SENT sid="1" pm="."><plain>A blunted TRH-TSH test, suggestive of <z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">thyrotoxicosis</z:e>, was found in 5 patients in Group I, 8 patients in Group II, and 2 patients in Group III </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis of <z:hpo ids='HP_0000836'>hyperthyroidism</z:hpo> was confirmed in 8 patients (by repeated TRH-TSH test and scintigraphy): 4 patients in Group I (12.1%) and 4 patients in Group II (12.9%) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of them had a nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">Thyrotoxicosis</z:e> should not be recognized in 6 of them if TRH-TSH test was not performed, because peripheral hormone levels were <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Five of these 8 patients with <z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">thyrotoxicosis</z:e> had reversion to sinus rhythm after treatment with <z:chebi fb="0" ids="617099">carbimazole</z:chebi>, either spontaneously or after cardioversion </plain></SENT>
<SENT sid="6" pm="."><plain>This outcome prevented prolongation of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy for an indefinite time </plain></SENT>
</text></document>